420+
Clinical studies completed for diseases across the metabolic continuum
20
Contributions to 20 approved metabolic drugs and devices
20+
Years as the leading clinical research provider for metabolic diseases
ProSciento has supported research for the advancement of nearly all medically relevant drug classes and devices for diabetes, NASH, and obesity and contributed to the evolution of advanced methods for nearly two decades.
Clinical studies completed for diseases across the metabolic continuum
Contributions to 20 approved metabolic drugs and devices
Years as the leading clinical research provider for metabolic diseases